Dr. Yoland Catherine Antill on Results of the PHAEDRA Trial

Leggi l'articolo originale


Cancer Network spoke with Yoland Catherine Antill, MD, of Cabrini Health, about the phase II PHAEDRA trial, which tested the activity of durvalumab in advanced endometrial cancer according to mismatch repair status.

Lascia un commento